Verhoef J, Rozenberg-Arska M, Dekker A
Department of Clinical Microbiology-Infectious Diseases, University Hospital, Utrecht, The Netherlands.
Rev Infect Dis. 1989 Nov-Dec;11 Suppl 7:S1545-50. doi: 10.1093/clinids/11.supplement_7.s1545.
All adult patients with acute nonlymphocytic leukemia--either first diagnosed or in relapse--who were admitted to University Hospital (Utrecht) between 1 December 1978 and 1 November 1980 were randomly assigned to a control group or to a group that received trimethoprim-sulfamethoxazole (TMP-SMZ) prophylactically; those admitted between 30 November 1980 and 1 December 1981 received a regimen of TMP-SMZ plus colistin; those admitted from 1 December 1981 to 1 December 1983 were randomized to receive TMP-SMZ plus colistin or neomycin plus colistin; and those admitted after 1 December 1983 were randomized to receive either ciprofloxacin alone or TMP-SMZ plus colistin. All agents were capable of preventing infections. However, the use of TMP-SMZ alone led to an increase in the number of infections caused by multiresistant microorganisms. The combination of TMP-SMZ plus colistin was superior to that of neomycin plus colistin. The new quinolone derivative ciprofloxacin was more effective than TMP-SMZ and was well tolerated. Antimicrobial prophylaxis with agents that provide adequate levels of drug in tissue prevents infections in granulocytopenic patients and is superior to that with nonabsorbable agents.
1978年12月1日至1980年11月1日期间入住乌得勒支大学医院的所有成年急性非淋巴细胞白血病患者(无论是初诊还是复发)被随机分为对照组或接受甲氧苄啶 - 磺胺甲恶唑(TMP - SMZ)预防性治疗的组;1980年11月30日至1981年12月1日期间入住的患者接受TMP - SMZ加黏菌素的治疗方案;1981年12月1日至1983年12月1日期间入住的患者被随机分配接受TMP - SMZ加黏菌素或新霉素加黏菌素治疗;1983年12月1日后入住的患者被随机分配接受单独环丙沙星或TMP - SMZ加黏菌素治疗。所有药物都能预防感染。然而,单独使用TMP - SMZ导致多重耐药微生物引起的感染数量增加。TMP - SMZ加黏菌素的组合优于新霉素加黏菌素。新型喹诺酮衍生物环丙沙星比TMP - SMZ更有效且耐受性良好。使用能在组织中提供足够药物水平的药物进行抗菌预防可预防粒细胞减少患者的感染,且优于使用不可吸收药物的预防方法。